Market Flux
Open the Terminal

Most Active

Neuronetics Prices 18.75 Million Share Offering at $1.60, Raising $30 Million Gross

By Market Flux··1 min read
Read this in the Market Flux app

Neuronetics, Inc. $STIM

$1.60-20.60%as of publication

5D Change
-40.85%
Notional
$15.73M

Neuronetics priced a public offering of 18.75 million shares at $1.60 per share on November 11, expecting approximately $30 million in gross proceeds. The price represents a significant discount to the stock's prior trading levels, with shares falling roughly 11-14% in premarket trading following the announcement.

© AI-generated summary is provided by Market Flux

Sources

  1. BriefingcomGapping up: $FOSL +25.1% $CRWV +17.3% $BGS +8.6% $MRVL +8.6% $SKHY +8.2% Gapping down: $SUJA -18.1% $BV -15.4% $ATRO -12.9% $STIM -11.4%
  2. BPharmCatalyst$STXS secured a convertible note agreement for up to $24 million, with an initial $12 million tranche and $12 million tied to milestones. The 10% interest notes convert at $1.21 per share. The capital boosts R&D and commercialization liquidity, though it adds interest costs and dilution risk as the company targets profitability. $PEPG $STXS $XCUR $STIM $SNOA $GOSS $CLLS $ALGS $INO $MDAI See More Pre-market Movers at BioPharmCatalyst in the Articles Menu
  3. OpenOutcrier$STIM (-13.9% pre) Neuronetics prices $30M stock offering at $1.60 per share